Search is Powered by Google
Bio-terrorism / Terrorism News

Splinternet Introduces GammaTect Plus(TM) To The Radiation Detection Marketplace To Protect Against Dirty Bombs

Main Category: Bio-terrorism / Terrorism
Article Date: 28 Mar 2008 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Splinternet Holdings, Inc., (OTC BB: SLNH.OB) announced today a highly sophisticated integrated gamma radiation detection sensor system called GammaTect Plus™, in the fight against the potential threat of a dirty bomb.

The quantities of radioactive materials stored at commercial sites combined with relatively ineffective security standards make hospitals and irradiation facilities prime targets for those seeking ingredients for terrorism. Less than 100 curies of Cesium-137, widely used in cancer therapy machines or Cobalt 60, used to irradiate food, combined with explosives could result in a radiological dispersal device (RDD). Detonated in New York's Grand Central Station, it would cause maximum economic and psychological disruption and require years of radioactive shrapnel cleanup before the landmark transportation hub could be safely used again.

GammaTect Plus™ is designed to be strategically deployed at radioactive storage sites, seaports, airports, government buildings, military installations, power plants and border crossings. It links into Splinternet's DefenTect™ management, monitoring and alerting system.

Scintillator-based, GammaTect Plus™ enables real-time alerts and gamma radiation isotope identification in an unattended perimeter or portal network. If threat-level high energy gamma violations occur, a series of photographs are taken by integral digital cameras. During a high radiological count event, photos, isotope ID and date are sent to a remote command center, triggering an alarm. System administrators can designate alerts to be triggered to PDAs, cell phones, pagers or other mobile clients.

GammaTect Plus™ combines passive surveillance with active alarms and can be set to ignore medical or other benign environmental isotopes. Even high radiation areas may be monitored since the system automatically subtracts predictive background radiation. Set in "patient mode," individuals undergoing medical treatments pass without triggering innocent alarms.

"Splinternet is committed to creating a critical part of the protection network against radiological terrorism," said James Ackerly, CEO of Splinternet. "GammaTect Plus is a next generation radiological detection system that we are accelerating to market."

Developed by JRT Calibration Services and re-architected by Splinternet, GammaTect Plus™ combines sensors with audio and visual alarms and charge coupled device cameras that can be connected to remote locations. GammaTect Plus™ samples the environment every 1 millisecond for the detection and identification of gamma emitting isotopes. Logs of each violation including time, date, isotope ID and photo are automatically transmitted to a remote command station for alerting and permanent record keeping.

About JRT Calibration Services

During its 12 years of operation, JRT Calibration Services has calibrated and repaired hundreds of types of radiation detection instruments from over 150 equipment manufacturers. Its staff has more than 30 years experience in the performance of instrument calibrations as well as the diagnosis, repair, and maintenance of highly specialized radiation detection equipment. JRT is professionally trained in the use of the equipment and radioactive sources necessary to provide the most reliable instrument calibration and equipment service.

About Splinternet Holdings, Inc.

Splinternet Holdings, Inc., based in Norwalk, Connecticut, is a developer of products, services and marketing strategies centered around opportunities in Internet communications. The development of radiation detection systems signals a broadening of Splinternet's scope to take advantage of opportunities found in related technologies. Splinternet Holdings is actively seeking investment opportunities in private and publicly-held businesses with strategic technology and market fit which would benefit from using web-based communications. Splinternet is publicly traded (OTC BB: SLNH.OB).

http://www.splinter.net




Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Breast Cancer Cardiovascular GI Prostate Cancer Psychiatry Respiratory Learning Resources Migraine Urology
Asthma Bipolar Blood Pressure Breast Cancer (Patient) Heartburn

Sign up to receive newsletters / news alerts
MedReader RSS Reader


Menopause - Managing the Symptoms
Menopause - Managing the Symptoms

While most women won't need to be treated for menopause, some will have symptoms severe enough to disrupt their lives. There are effective treatments to help those women cope with their symptoms.

more videos are available in our health videos section.

Add Your Advertisement Here